Filing since March 2025
Longevity Correspondent
David Ikemba
A practicing geriatrician at Johns Hopkins. His beat covers aging biomarkers, senolytics, and the rapamycin-in-humans trials.
- Bylines on file
- 19
- Filing since
- March 2025
- On the masthead
- 1 years
- Filed from
- Baltimore, Maryland
- Desk
- Longevity desk (lead writer)
- Pronouns
- he / him
David joined the desk in 2025 from an assistant professorship at Johns Hopkins. He still rounds two afternoons a week on the geriatric inpatient service, which he will tell you is the part of his week that keeps the longevity-industrial complex honest.
He writes about the gap between what a supplement company can claim and what a clinical trial can show — and about the smaller, more useful gap between an epigenetic clock and a functional outcome.
The point of this field is not living longer. It is what you can still do at eighty. I write for the readers who already know the difference. — Ikemba, in conversation with the newsroom